Evidence map›Paper›PMID 36684699›Full record

ArticleJournal of medical physics

Investigation of Different Components of Parallel-Hole Collimator Response to Different Radioisotope Energies Used in Nuclear Medicine Imaging.

Mahsa Noori-Asl, Sara Jeddi-Dashghapou

Abstract read
In one paragraph

Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mahsa Noori-AslDepartment of Physics, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran.
Sara Jeddi-DashghapouDepartment of Physics, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The quality of images obtained from the nuclear medicine imaging systems depends on different factors. One of the most important of these factors is the geometrical and physical characteristics of collimator used for imaging with a given radioisotope. Aims and Objectives: The aim of this study is to investigate the contribution of different components of collimator response for determining the most suitable parallel-hole collimator for the different radioisotope energies used in nuclear medicine imaging. Materials and Methods: In this study, the SIMIND Monte Carlo simulation program is used to determine the contribution of geometrical, penetrating and scattered response components of four hexagonal parallel-hole collimators including low-energy high-resolution (LEHR), low-energy general-purpose (LEGP), medium-energy general-purpose (MEGP), and high-energy general-purpose (HEGP) collimators, for 12 different energies used in nuclear medicine imaging. Results: According to the simulation results, the use of both the LEHR and LEGP collimators leads to a geometrical component above 60% for energies between 69 and 171 keV. On the other hand, for energies between 185 and 245 keV, the MEGP collimator and for energy of 364 keV, the HEGP collimator gives the geometrical components above 70% and 60%, respectively, while for energy of 511 keV, the geometrical response of all four collimators is below 20%. Conclusion: The results of this study show that for two low-energy single-photopeak radioisotopes, Tc-99m and I-123, the LEHR and LEGP collimators, and for high-energy single-photopeak radioisotope, I-131, the HEGP collimator are most suitable collimators. For dual-photopeak In-111 radioisotope and triple-photopeak Ga-67 radioisotope, the MEGP and HEGP collimators and for triple-photopeak Tl-201 radioisotopes, the LEHR and LEGP collimators are proposed as most suitable collimators.

Indexed as

Collimator responseMonte Carlo simulationnuclear medicine imaging

Identifiers

PMID36684699
PMCPMC9846997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.